Annual Operating Profit
-$31.92 M
-$11.99 M-60.20%
December 31, 2023
Summary
- As of February 7, 2025, AIM annual operating income is -$31.92 million, with the most recent change of -$11.99 million (-60.20%) on December 31, 2023.
- During the last 3 years, AIM annual operating profit has fallen by -$16.90 million (-112.53%).
- AIM annual operating profit is now -3091.60% below its all-time high of -$1.00 million, reached on December 31, 1995.
Performance
AIM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$4.49 M
-$795.00 K-21.52%
September 30, 2024
Summary
- As of February 7, 2025, AIM quarterly operating income is -$4.49 million, with the most recent change of -$795.00 thousand (-21.52%) on September 30, 2024.
- Over the past year, AIM quarterly operating profit has increased by +$9.52 million (+67.94%).
- AIM quarterly operating profit is now -741.29% below its all-time high of $700.00 thousand, reached on March 31, 1995.
Performance
AIM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$27.92 M
+$3.67 M+11.61%
September 30, 2024
Summary
- As of February 7, 2025, AIM TTM operating income is -$27.92 million, with the most recent change of +$3.67 million (+11.61%) on September 30, 2024.
- Over the past year, AIM TTM operating profit has increased by +$4.00 million (+12.52%).
- AIM TTM operating profit is now -1429.57% below its all-time high of $2.10 million, reached on September 30, 1995.
Performance
AIM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AIM Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -60.2% | +67.9% | +12.5% |
3 y3 years | -112.5% | +17.8% | -27.9% |
5 y5 years | -177.6% | +17.8% | -27.9% |
AIM Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -87.1% | at low | -42.4% | +67.9% | -69.6% | +16.3% |
5 y | 5-year | -156.5% | at low | -45.4% | +67.9% | -124.4% | +16.3% |
alltime | all time | -3091.6% | at low | -741.3% | +67.9% | -1429.6% | +16.3% |
AIM ImmunoTech Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$4.49 M(+21.5%) | -$27.92 M(-11.6%) |
Jun 2024 | - | -$3.69 M(-35.6%) | -$31.59 M(-5.3%) |
Mar 2024 | - | -$5.73 M(-59.1%) | -$33.36 M(+4.5%) |
Dec 2023 | -$31.92 M(+60.2%) | -$14.00 M(+71.7%) | -$31.92 M(+36.0%) |
Sep 2023 | - | -$8.16 M(+49.4%) | -$23.47 M(+7.5%) |
Jun 2023 | - | -$5.46 M(+27.1%) | -$21.83 M(+3.6%) |
Mar 2023 | - | -$4.29 M(-22.7%) | -$21.07 M(+5.7%) |
Dec 2022 | -$19.92 M(+16.8%) | -$5.56 M(-14.8%) | -$19.92 M(-0.5%) |
Sep 2022 | - | -$6.52 M(+38.9%) | -$20.03 M(+14.9%) |
Jun 2022 | - | -$4.70 M(+49.0%) | -$17.44 M(+5.9%) |
Mar 2022 | - | -$3.15 M(-44.4%) | -$16.46 M(-3.5%) |
Dec 2021 | -$17.06 M(+13.6%) | -$5.67 M(+44.2%) | -$17.06 M(+4.0%) |
Sep 2021 | - | -$3.93 M(+5.7%) | -$16.41 M(+3.6%) |
Jun 2021 | - | -$3.72 M(-0.7%) | -$15.83 M(+2.4%) |
Mar 2021 | - | -$3.75 M(-25.3%) | -$15.46 M(+2.8%) |
Dec 2020 | -$15.02 M(+20.7%) | -$5.01 M(+49.5%) | -$15.04 M(+14.7%) |
Sep 2020 | - | -$3.35 M(+0.4%) | -$13.11 M(+1.2%) |
Jun 2020 | - | -$3.34 M(+0.5%) | -$12.96 M(+0.9%) |
Mar 2020 | - | -$3.33 M(+7.7%) | -$12.84 M(+3.2%) |
Dec 2019 | -$12.44 M(+8.2%) | -$3.09 M(-3.7%) | -$12.44 M(+3.6%) |
Sep 2019 | - | -$3.21 M(-0.6%) | -$12.02 M(+1.4%) |
Jun 2019 | - | -$3.22 M(+10.2%) | -$11.85 M(-0.0%) |
Mar 2019 | - | -$2.93 M(+10.0%) | -$11.85 M(+3.1%) |
Dec 2018 | -$11.50 M(+0.7%) | -$2.66 M(-12.4%) | -$11.50 M(-1.1%) |
Sep 2018 | - | -$3.04 M(-5.9%) | -$11.63 M(+3.4%) |
Jun 2018 | - | -$3.23 M(+25.6%) | -$11.24 M(+4.6%) |
Mar 2018 | - | -$2.57 M(-8.0%) | -$10.74 M(-5.9%) |
Dec 2017 | -$11.42 M(-17.3%) | -$2.79 M(+5.3%) | -$11.42 M(-10.2%) |
Sep 2017 | - | -$2.65 M(-2.9%) | -$12.71 M(-4.3%) |
Jun 2017 | - | -$2.73 M(-15.8%) | -$13.28 M(-0.6%) |
Mar 2017 | - | -$3.24 M(-20.7%) | -$13.37 M(-3.2%) |
Dec 2016 | -$13.80 M(-17.1%) | -$4.08 M(+26.6%) | -$13.80 M(+9.9%) |
Sep 2016 | - | -$3.23 M(+14.6%) | -$12.56 M(-5.7%) |
Jun 2016 | - | -$2.81 M(-23.5%) | -$13.32 M(-13.5%) |
Mar 2016 | - | -$3.68 M(+29.4%) | -$15.41 M(-7.5%) |
Dec 2015 | -$16.65 M(-12.8%) | -$2.84 M(-28.6%) | -$16.65 M(-9.4%) |
Sep 2015 | - | -$3.98 M(-18.7%) | -$18.38 M(-1.8%) |
Jun 2015 | - | -$4.90 M(-0.4%) | -$18.73 M(-1.0%) |
Mar 2015 | - | -$4.92 M(+7.7%) | -$18.91 M(-1.0%) |
Dec 2014 | -$19.10 M(+11.3%) | -$4.57 M(+5.6%) | -$19.10 M(+6.5%) |
Sep 2014 | - | -$4.33 M(-14.9%) | -$17.94 M(-0.7%) |
Jun 2014 | - | -$5.08 M(-0.5%) | -$18.07 M(+2.0%) |
Mar 2014 | - | -$5.11 M(+49.8%) | -$17.72 M(+3.2%) |
Dec 2013 | -$17.17 M(-15.6%) | -$3.41 M(-23.5%) | -$17.17 M(-21.1%) |
Sep 2013 | - | -$4.46 M(-5.8%) | -$21.75 M(-2.3%) |
Jun 2013 | - | -$4.73 M(+3.8%) | -$22.26 M(+5.2%) |
Mar 2013 | - | -$4.56 M(-42.9%) | -$21.16 M(+4.0%) |
Dec 2012 | -$20.34 M(+42.3%) | -$8.00 M(+61.0%) | -$20.34 M(+25.2%) |
Sep 2012 | - | -$4.96 M(+36.7%) | -$16.25 M(+9.5%) |
Jun 2012 | - | -$3.63 M(-3.0%) | -$14.84 M(+2.7%) |
Mar 2012 | - | -$3.75 M(-3.9%) | -$14.45 M(+1.1%) |
Dec 2011 | -$14.29 M(-12.8%) | -$3.90 M(+9.6%) | -$14.29 M(-6.3%) |
Sep 2011 | - | -$3.56 M(+9.5%) | -$15.25 M(-0.9%) |
Jun 2011 | - | -$3.25 M(-9.5%) | -$15.38 M(-3.3%) |
Mar 2011 | - | -$3.59 M(-26.0%) | -$15.90 M(-2.9%) |
Dec 2010 | -$16.39 M(+23.5%) | -$4.85 M(+31.4%) | -$16.39 M(+5.7%) |
Sep 2010 | - | -$3.69 M(-2.0%) | -$15.51 M(+8.6%) |
Jun 2010 | - | -$3.77 M(-7.5%) | -$14.27 M(-1.4%) |
Mar 2010 | - | -$4.07 M(+2.5%) | -$14.48 M(+9.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | -$13.26 M(+3.5%) | -$3.97 M(+61.7%) | -$13.26 M(+8.1%) |
Sep 2009 | - | -$2.46 M(-38.2%) | -$12.28 M(-7.5%) |
Jun 2009 | - | -$3.98 M(+39.5%) | -$13.27 M(+6.8%) |
Mar 2009 | - | -$2.85 M(-4.4%) | -$12.42 M(-3.1%) |
Dec 2008 | -$12.81 M(-33.6%) | -$2.98 M(-13.5%) | -$12.81 M(-7.4%) |
Sep 2008 | - | -$3.45 M(+10.3%) | -$13.84 M(-16.5%) |
Jun 2008 | - | -$3.13 M(-3.5%) | -$16.57 M(-5.8%) |
Mar 2008 | - | -$3.25 M(-19.1%) | -$17.59 M(-8.8%) |
Dec 2007 | -$19.29 M(+3.2%) | -$4.01 M(-35.1%) | -$19.29 M(-2.1%) |
Sep 2007 | - | -$6.18 M(+48.6%) | -$19.70 M(+13.3%) |
Jun 2007 | - | -$4.16 M(-15.8%) | -$17.38 M(-3.7%) |
Mar 2007 | - | -$4.94 M(+11.8%) | -$18.05 M(-3.5%) |
Dec 2006 | -$18.69 M(+88.5%) | -$4.42 M(+14.4%) | -$18.70 M(+7.6%) |
Sep 2006 | - | -$3.86 M(-19.9%) | -$17.38 M(+10.6%) |
Jun 2006 | - | -$4.83 M(-13.6%) | -$15.71 M(+17.5%) |
Mar 2006 | - | -$5.59 M(+80.0%) | -$13.37 M(+34.8%) |
Dec 2005 | -$9.91 M(-8.9%) | -$3.10 M(+41.5%) | -$9.92 M(+14.1%) |
Sep 2005 | - | -$2.19 M(-11.7%) | -$8.69 M(-5.7%) |
Jun 2005 | - | -$2.48 M(+16.3%) | -$9.21 M(+3.2%) |
Mar 2005 | - | -$2.13 M(+13.6%) | -$8.92 M(-18.1%) |
Dec 2004 | -$10.89 M(+50.2%) | -$1.88 M(-30.7%) | -$10.89 M(-3.4%) |
Sep 2004 | - | -$2.71 M(+23.6%) | -$11.27 M(+9.2%) |
Jun 2004 | - | -$2.19 M(-46.5%) | -$10.32 M(+5.7%) |
Mar 2004 | - | -$4.10 M(+81.6%) | -$9.76 M(+34.6%) |
Dec 2003 | -$7.25 M(+9.5%) | -$2.26 M(+27.9%) | -$7.25 M(+15.8%) |
Sep 2003 | - | -$1.77 M(+7.9%) | -$6.26 M(-1.8%) |
Jun 2003 | - | -$1.64 M(+2.8%) | -$6.38 M(-4.9%) |
Mar 2003 | - | -$1.59 M(+25.7%) | -$6.70 M(+1.3%) |
Dec 2002 | -$6.62 M(-24.8%) | -$1.27 M(-32.7%) | -$6.62 M(-5.7%) |
Sep 2002 | - | -$1.88 M(-4.1%) | -$7.02 M(-4.2%) |
Jun 2002 | - | -$1.96 M(+30.2%) | -$7.32 M(-5.7%) |
Mar 2002 | - | -$1.51 M(-9.4%) | -$7.76 M(-11.8%) |
Dec 2001 | -$8.80 M(-2.7%) | -$1.66 M(-23.9%) | -$8.80 M(-9.0%) |
Sep 2001 | - | -$2.19 M(-9.0%) | -$9.68 M(-0.0%) |
Jun 2001 | - | -$2.40 M(-5.7%) | -$9.68 M(+2.2%) |
Mar 2001 | - | -$2.55 M(+0.5%) | -$9.47 M(+4.7%) |
Dec 2000 | -$9.04 M(-29.2%) | -$2.54 M(+16.0%) | -$9.04 M(-22.3%) |
Sep 2000 | - | -$2.19 M(-0.3%) | -$11.64 M(+1.4%) |
Jun 2000 | - | -$2.19 M(+3.3%) | -$11.48 M(-4.2%) |
Mar 2000 | - | -$2.12 M(-58.6%) | -$11.99 M(-6.6%) |
Dec 1999 | -$12.78 M(+77.5%) | -$5.13 M(+152.7%) | -$12.83 M(+33.7%) |
Sep 1999 | - | -$2.03 M(-24.7%) | -$9.60 M(+3.6%) |
Jun 1999 | - | -$2.70 M(-9.0%) | -$9.27 M(+12.1%) |
Mar 1999 | - | -$2.97 M(+56.3%) | -$8.27 M(+19.8%) |
Dec 1998 | -$7.20 M(+12.5%) | -$1.90 M(+11.7%) | -$6.90 M(+4.5%) |
Sep 1998 | - | -$1.70 M(0.0%) | -$6.60 M(+3.1%) |
Jun 1998 | - | -$1.70 M(+6.3%) | -$6.40 M(+10.3%) |
Mar 1998 | - | -$1.60 M(0.0%) | -$5.80 M(-12.1%) |
Dec 1997 | -$6.40 M(+33.3%) | -$1.60 M(+6.7%) | -$6.60 M(+3.1%) |
Sep 1997 | - | -$1.50 M(+36.4%) | -$6.40 M(0.0%) |
Jun 1997 | - | -$1.10 M(-54.2%) | -$6.40 M(+1.6%) |
Mar 1997 | - | -$2.40 M(+71.4%) | -$6.30 M(+37.0%) |
Dec 1996 | -$4.80 M(+380.0%) | -$1.40 M(-6.7%) | -$4.60 M(-27.0%) |
Sep 1996 | - | -$1.50 M(+50.0%) | -$6.30 M(+53.7%) |
Jun 1996 | - | -$1.00 M(+42.9%) | -$4.10 M(+70.8%) |
Mar 1996 | - | -$700.00 K(-77.4%) | -$2.40 M(+140.0%) |
Dec 1995 | -$1.00 M | -$3.10 M(-542.9%) | -$1.00 M(-147.6%) |
Sep 1995 | - | $700.00 K(0.0%) | $2.10 M(+50.0%) |
Jun 1995 | - | $700.00 K(0.0%) | $1.40 M(+100.0%) |
Mar 1995 | - | $700.00 K | $700.00 K |
FAQ
- What is AIM ImmunoTech annual operating income?
- What is the all time high annual operating profit for AIM ImmunoTech?
- What is AIM ImmunoTech annual operating profit year-on-year change?
- What is AIM ImmunoTech quarterly operating income?
- What is the all time high quarterly operating profit for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly operating profit year-on-year change?
- What is AIM ImmunoTech TTM operating income?
- What is the all time high TTM operating profit for AIM ImmunoTech?
- What is AIM ImmunoTech TTM operating profit year-on-year change?
What is AIM ImmunoTech annual operating income?
The current annual operating profit of AIM is -$31.92 M
What is the all time high annual operating profit for AIM ImmunoTech?
AIM ImmunoTech all-time high annual operating income is -$1.00 M
What is AIM ImmunoTech annual operating profit year-on-year change?
Over the past year, AIM annual operating income has changed by -$11.99 M (-60.20%)
What is AIM ImmunoTech quarterly operating income?
The current quarterly operating profit of AIM is -$4.49 M
What is the all time high quarterly operating profit for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly operating income is $700.00 K
What is AIM ImmunoTech quarterly operating profit year-on-year change?
Over the past year, AIM quarterly operating income has changed by +$9.52 M (+67.94%)
What is AIM ImmunoTech TTM operating income?
The current TTM operating profit of AIM is -$27.92 M
What is the all time high TTM operating profit for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM operating income is $2.10 M
What is AIM ImmunoTech TTM operating profit year-on-year change?
Over the past year, AIM TTM operating income has changed by +$4.00 M (+12.52%)